Global Adoptive Cell Therapy Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Global Adoptive Cell Therapy Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Adoptive Cell Therapy Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 CAR-T
1.2.3 TCR-T
1.2.4 NK
1.2.5 TIL
1.3 Market by Application
1.3.1 Global Adoptive Cell Therapy Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Lymphoma
1.3.3 Leukemia
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Adoptive Cell Therapy Market Size (2017-2028)
2.2 Adoptive Cell Therapy Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Adoptive Cell Therapy Market Size by Region (2017-2022)
2.4 Global Adoptive Cell Therapy Market Size Forecast by Region (2023-2028)
2.5 Global Top Adoptive Cell Therapy Countries Ranking by Market Size
3 Adoptive Cell Therapy Competitive by Company
3.1 Global Adoptive Cell Therapy Revenue by Players
3.1.1 Global Adoptive Cell Therapy Revenue by Players (2017-2022)
3.1.2 Global Adoptive Cell Therapy Market Share by Players (2017-2022)
3.2 Global Adoptive Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Adoptive Cell Therapy Revenue
3.4 Global Adoptive Cell Therapy Market Concentration Ratio
3.4.1 Global Adoptive Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Adoptive Cell Therapy Revenue in 2021
3.5 Global Adoptive Cell Therapy Key Players Head office and Area Served
3.6 Key Players Adoptive Cell Therapy Product Solution and Service
3.7 Date of Enter into Adoptive Cell Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Adoptive Cell Therapy Breakdown Data by Type
4.1 Global Adoptive Cell Therapy Historic Revenue by Type (2017-2022)
4.2 Global Adoptive Cell Therapy Forecasted Revenue by Type (2023-2028)
5 Global Adoptive Cell Therapy Breakdown Data by Application
5.1 Global Adoptive Cell Therapy Historic Market Size by Application (2017-2022)
5.2 Global Adoptive Cell Therapy Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Adoptive Cell Therapy Revenue by Company (2020-2022)
6.2 North America Adoptive Cell Therapy Revenue by Type (2017-2028)
6.3 North America Adoptive Cell Therapy Revenue by Application (2017-2028)
6.4 North America Adoptive Cell Therapy Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Adoptive Cell Therapy Revenue by Company (2020-2022)
7.2 Europe Adoptive Cell Therapy Revenue by Type (2017-2028)
7.3 Europe Adoptive Cell Therapy Revenue by Application (2017-2028)
7.4 Europe Adoptive Cell Therapy Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Adoptive Cell Therapy Revenue by Company (2020-2022)
8.2 Asia Pacific Adoptive Cell Therapy Revenue by Type (2017-2028)
8.3 Asia Pacific Adoptive Cell Therapy Revenue by Application (2017-2028)
8.4 Asia Pacific Adoptive Cell Therapy Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Adoptive Cell Therapy Revenue by Company (2020-2022)
9.2 Latin America Adoptive Cell Therapy Revenue by Type (2017-2028)
9.3 Latin America Adoptive Cell Therapy Revenue by Application (2017-2028)
9.4 Latin America Adoptive Cell Therapy Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Adoptive Cell Therapy Revenue by Company (2020-2022)
10.2 Middle East and Africa Adoptive Cell Therapy Revenue by Type (2017-2028)
10.3 Middle East and Africa Adoptive Cell Therapy Revenue by Application (2017-2028)
10.4 Middle East and Africa Adoptive Cell Therapy Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 U.A.E
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Adoptive Cell Therapy Products and Services
11.1.4 Novartis Adoptive Cell Therapy Revenue in Adoptive Cell Therapy Business (2017-2022)
11.1.5 Novartis Adoptive Cell Therapy SWOT Analysis
11.1.6 Novartis Recent Developments
11.2 Juno
11.2.1 Juno Company Details
11.2.2 Juno Business Overview
11.2.3 Juno Adoptive Cell Therapy Products and Services
11.2.4 Juno Adoptive Cell Therapy Revenue in Adoptive Cell Therapy Business (2017-2022)
11.2.5 Juno Adoptive Cell Therapy SWOT Analysis
11.2.6 Juno Recent Developments
11.3 Kite
11.3.1 Kite Company Details
11.3.2 Kite Business Overview
11.3.3 Kite Adoptive Cell Therapy Products and Services
11.3.4 Kite Adoptive Cell Therapy Revenue in Adoptive Cell Therapy Business (2017-2022)
11.3.5 Kite Adoptive Cell Therapy SWOT Analysis
11.3.6 Kite Recent Developments
11.4 Adaptimmune
11.4.1 Adaptimmune Company Details
11.4.2 Adaptimmune Business Overview
11.4.3 Adaptimmune Adoptive Cell Therapy Products and Services
11.4.4 Adaptimmune Adoptive Cell Therapy Revenue in Adoptive Cell Therapy Business (2017-2022)
11.4.5 Adaptimmune Adoptive Cell Therapy SWOT Analysis
11.4.6 Adaptimmune Recent Developments
11.5 Fibrocell
11.5.1 Fibrocell Company Details
11.5.2 Fibrocell Business Overview
11.5.3 Fibrocell Adoptive Cell Therapy Products and Services
11.5.4 Fibrocell Adoptive Cell Therapy Revenue in Adoptive Cell Therapy Business (2017-2022)
11.5.5 Fibrocell Adoptive Cell Therapy SWOT Analysis
11.5.6 Fibrocell Recent Developments
11.6 Lineage Cell Therapeutics
11.6.1 Lineage Cell Therapeutics Company Details
11.6.2 Lineage Cell Therapeutics Business Overview
11.6.3 Lineage Cell Therapeutics Adoptive Cell Therapy Products and Services
11.6.4 Lineage Cell Therapeutics Adoptive Cell Therapy Revenue in Adoptive Cell Therapy Business (2017-2022)
11.6.5 Lineage Cell Therapeutics Adoptive Cell Therapy SWOT Analysis
11.6.6 Lineage Cell Therapeutics Recent Developments
11.7 BioTime
11.7.1 BioTime Company Details
11.7.2 BioTime Business Overview
11.7.3 BioTime Adoptive Cell Therapy Products and Services
11.7.4 BioTime Adoptive Cell Therapy Revenue in Adoptive Cell Therapy Business (2017-2022)
11.7.5 BioTime Adoptive Cell Therapy SWOT Analysis
11.7.6 BioTime Recent Developments
11.8 Vericel Corporation
11.8.1 Vericel Corporation Company Details
11.8.2 Vericel Corporation Business Overview
11.8.3 Vericel Corporation Adoptive Cell Therapy Products and Services
11.8.4 Vericel Corporation Adoptive Cell Therapy Revenue in Adoptive Cell Therapy Business (2017-2022)
11.8.5 Vericel Corporation Adoptive Cell Therapy SWOT Analysis
11.8.6 Vericel Corporation Recent Developments
11.9 Regeneus
11.9.1 Regeneus Company Details
11.9.2 Regeneus Business Overview
11.9.3 Regeneus Adoptive Cell Therapy Products and Services
11.9.4 Regeneus Adoptive Cell Therapy Revenue in Adoptive Cell Therapy Business (2017-2022)
11.9.5 Regeneus Adoptive Cell Therapy SWOT Analysis
11.9.6 Regeneus Recent Developments
11.10 Anhui Anke Biotechnology
11.10.1 Anhui Anke Biotechnology Company Details
11.10.2 Anhui Anke Biotechnology Business Overview
11.10.3 Anhui Anke Biotechnology Adoptive Cell Therapy Products and Services
11.10.4 Anhui Anke Biotechnology Adoptive Cell Therapy Revenue in Adoptive Cell Therapy Business (2017-2022)
11.10.5 Anhui Anke Biotechnology Adoptive Cell Therapy SWOT Analysis
11.10.6 Anhui Anke Biotechnology Recent Developments
11.11 Cellectis
11.11.1 Cellectis Company Details
11.11.2 Cellectis Business Overview
11.11.3 Cellectis Adoptive Cell Therapy Products and Services
11.11.4 Cellectis Adoptive Cell Therapy Revenue in Adoptive Cell Therapy Business (2017-2022)
11.11.5 Cellectis Recent Developments
11.12 NantKwest
11.12.1 NantKwest Company Details
11.12.2 NantKwest Business Overview
11.12.3 NantKwest Adoptive Cell Therapy Products and Services
11.12.4 NantKwest Adoptive Cell Therapy Revenue in Adoptive Cell Therapy Business (2017-2022)
11.12.5 NantKwest Recent Developments
11.13 SorrentoTherapeutics
11.13.1 SorrentoTherapeutics Company Details
11.13.2 SorrentoTherapeutics Business Overview
11.13.3 SorrentoTherapeutics Adoptive Cell Therapy Products and Services
11.13.4 SorrentoTherapeutics Adoptive Cell Therapy Revenue in Adoptive Cell Therapy Business (2017-2022)
11.13.5 SorrentoTherapeutics Recent Developments
11.14 Bellicum
11.14.1 Bellicum Company Details
11.14.2 Bellicum Business Overview
11.14.3 Bellicum Adoptive Cell Therapy Products and Services
11.14.4 Bellicum Adoptive Cell Therapy Revenue in Adoptive Cell Therapy Business (2017-2022)
11.14.5 Bellicum Recent Developments
12 Adoptive Cell Therapy Market Dynamics
12.1 Adoptive Cell Therapy Market Trends
12.2 Adoptive Cell Therapy Market Drivers
12.3 Adoptive Cell Therapy Market Challenges
12.4 Adoptive Cell Therapy Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Tables
Table 1. Global Adoptive Cell Therapy Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of CAR-T
Table 3. Key Players of TCR-T
Table 4. Key Players of NK
Table 5. Key Players of TIL
Table 6. Global Adoptive Cell Therapy Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Adoptive Cell Therapy Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 8. Global Adoptive Cell Therapy Revenue by Region (2017-2022) & (US$ Million)
Table 9. Global Adoptive Cell Therapy Revenue Market Share by Region (2017-2022)
Table 10. Global Adoptive Cell Therapy Revenue by Players (2017-2022) & (US$ Million)
Table 11. Global Adoptive Cell Therapy Market Share by Players (2017-2022)
Table 12. Global Top Adoptive Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adoptive Cell Therapy as of 2021)
Table 13. Ranking of Global Top Adoptive Cell Therapy Companies by Revenue (US$ Million) in 2021
Table 14. Global 5 Largest Players Market Share by Adoptive Cell Therapy Revenue (CR5 and HHI) & (2017-2022)
Table 15. Key Players Headquarters and Area Served
Table 16. Key Players Adoptive Cell Therapy Product Solution and Service
Table 17. Date of Key Manufacturers Enter into Adoptive Cell Therapy Market
Table 18. Mergers & Acquisitions, Expansion Plans
Table 19. Global Adoptive Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 20. Global Adoptive Cell Therapy Revenue Market Share by Type (2017-2022)
Table 21. Global Adoptive Cell Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 22. Global Adoptive Cell Therapy Revenue Market Share by Type (2023-2028)
Table 23. Global Adoptive Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 24. Global Adoptive Cell Therapy Revenue Market Share by Application (2017-2022)
Table 25. Global Adoptive Cell Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 26. Global Adoptive Cell Therapy Revenue Market Share by Application (2023-2028)
Table 27. North America Adoptive Cell Therapy Revenue by Company (2020-2022) & (US$ Million)
Table 28. North America Adoptive Cell Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 29. North America Adoptive Cell Therapy Revenue by Type (2023-2028) & (US$ Million)
Table 30. North America Adoptive Cell Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 31. North America Adoptive Cell Therapy Revenue by Application (2023-2028) & (US$ Million)
Table 32. North America Adoptive Cell Therapy Revenue by Country (2017-2022) & (US$ Million)
Table 33. North America Adoptive Cell Therapy Revenue by Country (2023-2028) & (US$ Million)
Table 34. Europe Adoptive Cell Therapy Revenue by Company (2020-2022) & (US$ Million)
Table 35. Europe Adoptive Cell Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 36. Europe Adoptive Cell Therapy Revenue by Type (2023-2028) & (US$ Million)
Table 37. Europe Adoptive Cell Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 38. Europe Adoptive Cell Therapy Revenue by Application (2023-2028) & (US$ Million)
Table 39. Europe Adoptive Cell Therapy Revenue by Country (2017-2022) & (US$ Million)
Table 40. Europe Adoptive Cell Therapy Revenue by Country (2023-2028) & (US$ Million)
Table 41. Asia Pacific Adoptive Cell Therapy Revenue by Company (2020-2022) & (US$ Million)
Table 42. Asia Pacific Adoptive Cell Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 43. Asia Pacific Adoptive Cell Therapy Revenue by Type (2023-2028) & (US$ Million)
Table 44. Asia Pacific Adoptive Cell Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 45. Asia Pacific Adoptive Cell Therapy Revenue by Application (2023-2028) & (US$ Million)
Table 46. Asia Pacific Adoptive Cell Therapy Revenue by Region (2017-2022) & (US$ Million)
Table 47. Asia Pacific Adoptive Cell Therapy Revenue by Region (2023-2028) & (US$ Million)
Table 48. Latin America Adoptive Cell Therapy Revenue by Company (2020-2022) & (US$ Million)
Table 49. Latin America Adoptive Cell Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 50. Latin America Adoptive Cell Therapy Revenue by Type (2023-2028) & (US$ Million)
Table 51. Latin America Adoptive Cell Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 52. Latin America Adoptive Cell Therapy Revenue by Application (2023-2028) & (US$ Million)
Table 53. Latin America Adoptive Cell Therapy Revenue by Country (2017-2022) & (US$ Million)
Table 54. Latin America Adoptive Cell Therapy Revenue by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Adoptive Cell Therapy Revenue by Company (2020-2022) & (US$ Million)
Table 56. Middle East and Africa Adoptive Cell Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Adoptive Cell Therapy Revenue by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Adoptive Cell Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Adoptive Cell Therapy Revenue by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Adoptive Cell Therapy Revenue by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Adoptive Cell Therapy Revenue by Country (2023-2028) & (US$ Million)
Table 62. Novartis Company Details
Table 63. Novartis Business Overview
Table 64. Novartis Adoptive Cell Therapy Product and Services
Table 65. Novartis Adoptive Cell Therapy Revenue in Adoptive Cell Therapy Business (2017-2022) & (US$ Million)
Table 66. Novartis Adoptive Cell Therapy SWOT Analysis
Table 67. Novartis Recent Developments
Table 68. Juno Company Details
Table 69. Juno Business Overview
Table 70. Juno Adoptive Cell Therapy Product and Services
Table 71. Juno Adoptive Cell Therapy Revenue in Adoptive Cell Therapy Business (2017-2022) & (US$ Million)
Table 72. Juno Adoptive Cell Therapy SWOT Analysis
Table 73. Juno Recent Developments
Table 74. Kite Company Details
Table 75. Kite Business Overview
Table 76. Kite Adoptive Cell Therapy Product and Services
Table 77. Kite Adoptive Cell Therapy Revenue in Adoptive Cell Therapy Business (2017-2022) & (US$ Million)
Table 78. Kite Adoptive Cell Therapy SWOT Analysis
Table 79. Kite Recent Developments
Table 80. Adaptimmune Company Details
Table 81. Adaptimmune Business Overview
Table 82. Adaptimmune Adoptive Cell Therapy Product and Services
Table 83. Adaptimmune Adoptive Cell Therapy Revenue in Adoptive Cell Therapy Business (2017-2022) & (US$ Million)
Table 84. Adaptimmune Adoptive Cell Therapy SWOT Analysis
Table 85. Adaptimmune Recent Developments
Table 86. Fibrocell Company Details
Table 87. Fibrocell Business Overview
Table 88. Fibrocell Adoptive Cell Therapy Product and Services
Table 89. Fibrocell Adoptive Cell Therapy Revenue in Adoptive Cell Therapy Business (2017-2022) & (US$ Million)
Table 90. Fibrocell Adoptive Cell Therapy SWOT Analysis
Table 91. Fibrocell Recent Developments
Table 92. Lineage Cell Therapeutics Company Details
Table 93. Lineage Cell Therapeutics Business Overview
Table 94. Lineage Cell Therapeutics Adoptive Cell Therapy Product and Services
Table 95. Lineage Cell Therapeutics Adoptive Cell Therapy Revenue in Adoptive Cell Therapy Business (2017-2022) & (US$ Million)
Table 96. Lineage Cell Therapeutics Adoptive Cell Therapy SWOT Analysis
Table 97. Lineage Cell Therapeutics Recent Developments
Table 98. BioTime Company Details
Table 99. BioTime Business Overview
Table 100. BioTime Adoptive Cell Therapy Product and Services
Table 101. BioTime Adoptive Cell Therapy Revenue in Adoptive Cell Therapy Business (2017-2022) & (US$ Million)
Table 102. BioTime Adoptive Cell Therapy SWOT Analysis
Table 103. BioTime Recent Developments
Table 104. Vericel Corporation Company Details
Table 105. Vericel Corporation Business Overview
Table 106. Vericel Corporation Adoptive Cell Therapy Product and Services
Table 107. Vericel Corporation Adoptive Cell Therapy Revenue in Adoptive Cell Therapy Business (2017-2022) & (US$ Million)
Table 108. Vericel Corporation Adoptive Cell Therapy SWOT Analysis
Table 109. Vericel Corporation Recent Developments
Table 110. Regeneus Company Details
Table 111. Regeneus Business Overview
Table 112. Regeneus Adoptive Cell Therapy Product and Services
Table 113. Regeneus Adoptive Cell Therapy Revenue in Adoptive Cell Therapy Business (2017-2022) & (US$ Million)
Table 114. Regeneus Adoptive Cell Therapy SWOT Analysis
Table 115. Regeneus Recent Developments
Table 116. Anhui Anke Biotechnology Company Details
Table 117. Anhui Anke Biotechnology Business Overview
Table 118. Anhui Anke Biotechnology Adoptive Cell Therapy Product and Services
Table 119. Anhui Anke Biotechnology Adoptive Cell Therapy Revenue in Adoptive Cell Therapy Business (2017-2022) & (US$ Million)
Table 120. Anhui Anke Biotechnology Adoptive Cell Therapy SWOT Analysis
Table 121. Anhui Anke Biotechnology Recent Developments
Table 122. Cellectis Company Details
Table 123. Cellectis Business Overview
Table 124. Cellectis Adoptive Cell Therapy Product and Services
Table 125. Cellectis Adoptive Cell Therapy Revenue in Adoptive Cell Therapy Business (2017-2022) & (US$ Million)
Table 126. Cellectis Recent Developments
Table 127. NantKwest Company Details
Table 128. NantKwest Business Overview
Table 129. NantKwest Adoptive Cell Therapy Product and Services
Table 130. NantKwest Adoptive Cell Therapy Revenue in Adoptive Cell Therapy Business (2017-2022) & (US$ Million)
Table 131. NantKwest Recent Developments
Table 132. SorrentoTherapeutics Company Details
Table 133. SorrentoTherapeutics Business Overview
Table 134. SorrentoTherapeutics Adoptive Cell Therapy Product and Services
Table 135. SorrentoTherapeutics Adoptive Cell Therapy Revenue in Adoptive Cell Therapy Business (2017-2022) & (US$ Million)
Table 136. SorrentoTherapeutics Recent Developments
Table 137. Bellicum Company Details
Table 138. Bellicum Business Overview
Table 139. Bellicum Adoptive Cell Therapy Product and Services
Table 140. Bellicum Adoptive Cell Therapy Revenue in Adoptive Cell Therapy Business (2017-2022) & (US$ Million)
Table 141. Bellicum Recent Developments
Table 142. Adoptive Cell Therapy Market Trends
Table 143. Adoptive Cell Therapy Market Drivers
Table 144. Adoptive Cell Therapy Market Challenges
Table 145. Adoptive Cell Therapy Market Restraints
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Adoptive Cell Therapy Sales Market Share by Type: 2021 VS 2028
Figure 2. CAR-T Features
Figure 3. TCR-T Features
Figure 4. NK Features
Figure 5. TIL Features
Figure 6. Global Adoptive Cell Therapy Sales Market Share by Application: 2021 VS 2028
Figure 7. Lymphoma Case Studies
Figure 8. Leukemia Case Studies
Figure 9. Adoptive Cell Therapy Report Years Considered
Figure 10. Global Adoptive Cell Therapy Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Adoptive Cell Therapy Market Size 2017-2028 (US$ Million)
Figure 12. Global Adoptive Cell Therapy Market Size Market Share by Region: 2021 VS 2028
Figure 13. Global Adoptive Cell Therapy Revenue Market Share by Region in 2017 VS 2022
Figure 14. Global Top 10 Adoptive Cell Therapy Countries Ranking by Market Size (US$ Million) in 2021
Figure 15. Global Adoptive Cell Therapy Market Share by Players in 2021
Figure 16. Global Top Adoptive Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adoptive Cell Therapy as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Adoptive Cell Therapy Revenue in 2021
Figure 18. North America Adoptive Cell Therapy Revenue Market Share by Company in 2021
Figure 19. North America Adoptive Cell Therapy Revenue Market Share by Type (2017-2028)
Figure 20. North America Adoptive Cell Therapy Revenue Market Share by Application (2017-2028)
Figure 21. North America Adoptive Cell Therapy Revenue Share by Country (2017-2028)
Figure 22. U.S. Adoptive Cell Therapy Revenue (2017-2028) & (US$ Million)
Figure 23. Canada Adoptive Cell Therapy Revenue (2017-2028) & (US$ Million)
Figure 24. Europe Adoptive Cell Therapy Revenue Market Share by Company in 2021
Figure 25. Europe Adoptive Cell Therapy Revenue Market Share by Type (2017-2028)
Figure 26. Europe Adoptive Cell Therapy Revenue Market Share by Application (2017-2028)
Figure 27. Europe Adoptive Cell Therapy Revenue Share by Country (2017-2028)
Figure 28. Germany Adoptive Cell Therapy Revenue (2017-2028) & (US$ Million)
Figure 29. France Adoptive Cell Therapy Revenue (2017-2028) & (US$ Million)
Figure 30. U.K. Adoptive Cell Therapy Revenue (2017-2028) & (US$ Million)
Figure 31. Italy Adoptive Cell Therapy Revenue (2017-2028) & (US$ Million)
Figure 32. Russia Adoptive Cell Therapy Revenue (2017-2028) & (US$ Million)
Figure 33. Asia Pacific Adoptive Cell Therapy Revenue Market Share by Company in 2021
Figure 34. Asia Pacific Adoptive Cell Therapy Revenue Market Share by Type (2017-2028)
Figure 35. Asia Pacific Adoptive Cell Therapy Revenue Market Share by Application (2017-2028)
Figure 36. Asia Pacific Adoptive Cell Therapy Revenue Share by Region (2017-2028)
Figure 37. China Adoptive Cell Therapy Revenue (2017-2028) & (US$ Million)
Figure 38. Japan Adoptive Cell Therapy Revenue (2017-2028) & (US$ Million)
Figure 39. South Korea Adoptive Cell Therapy Revenue (2017-2028) & (US$ Million)
Figure 40. India Adoptive Cell Therapy Revenue (2017-2028) & (US$ Million)
Figure 41. Australia Adoptive Cell Therapy Revenue (2017-2028) & (US$ Million)
Figure 42. Taiwan Adoptive Cell Therapy Revenue (2017-2028) & (US$ Million)
Figure 43. Indonesia Adoptive Cell Therapy Revenue (2017-2028) & (US$ Million)
Figure 44. Thailand Adoptive Cell Therapy Revenue (2017-2028) & (US$ Million)
Figure 45. Malaysia Adoptive Cell Therapy Revenue (2017-2028) & (US$ Million)
Figure 46. Philippines Adoptive Cell Therapy Revenue (2017-2028) & (US$ Million)
Figure 47. Vietnam Adoptive Cell Therapy Revenue (2017-2028) & (US$ Million)
Figure 48. Latin America Adoptive Cell Therapy Revenue Market Share by Company in 2021
Figure 49. Latin America Adoptive Cell Therapy Revenue Market Share by Type (2017-2028)
Figure 50. Latin America Adoptive Cell Therapy Revenue Market Share by Application (2017-2028)
Figure 51. Latin America Adoptive Cell Therapy Revenue Share by Country (2017-2028)
Figure 52. Mexico Adoptive Cell Therapy Revenue (2017-2028) & (US$ Million)
Figure 53. Brazil Adoptive Cell Therapy Revenue (2017-2028) & (US$ Million)
Figure 54. Argentina Adoptive Cell Therapy Revenue (2017-2028) & (US$ Million)
Figure 55. Middle East and Africa Adoptive Cell Therapy Revenue Market Share by Company in 2021
Figure 56. Middle East and Africa Adoptive Cell Therapy Revenue Market Share by Type (2017-2028)
Figure 57. Middle East and Africa Adoptive Cell Therapy Revenue Market Share by Application (2017-2028)
Figure 58. Middle East and Africa Adoptive Cell Therapy Revenue Share by Country (2017-2028)
Figure 59. Turkey Adoptive Cell Therapy Revenue (2017-2028) & (US$ Million)
Figure 60. Saudi Arabia Adoptive Cell Therapy Revenue (2017-2028) & (US$ Million)
Figure 61. U.A.E Adoptive Cell Therapy Revenue (2017-2028) & (US$ Million)
Figure 62. Novartis Revenue Growth Rate in Adoptive Cell Therapy Business (2017-2022)
Figure 63. Juno Revenue Growth Rate in Adoptive Cell Therapy Business (2017-2022)
Figure 64. Kite Revenue Growth Rate in Adoptive Cell Therapy Business (2017-2022)
Figure 65. Adaptimmune Revenue Growth Rate in Adoptive Cell Therapy Business (2017-2022)
Figure 66. Fibrocell Revenue Growth Rate in Adoptive Cell Therapy Business (2017-2022)
Figure 67. Lineage Cell Therapeutics Revenue Growth Rate in Adoptive Cell Therapy Business (2017-2022)
Figure 68. BioTime Revenue Growth Rate in Adoptive Cell Therapy Business (2017-2022)
Figure 69. Vericel Corporation Revenue Growth Rate in Adoptive Cell Therapy Business (2017-2022)
Figure 70. Regeneus Revenue Growth Rate in Adoptive Cell Therapy Business (2017-2022)
Figure 71. Anhui Anke Biotechnology Revenue Growth Rate in Adoptive Cell Therapy Business (2017-2022)
Figure 72. Cellectis Revenue Growth Rate in Adoptive Cell Therapy Business (2017-2022)
Figure 73. NantKwest Revenue Growth Rate in Adoptive Cell Therapy Business (2017-2022)
Figure 74. SorrentoTherapeutics Revenue Growth Rate in Adoptive Cell Therapy Business (2017-2022)
Figure 75. Bellicum Revenue Growth Rate in Adoptive Cell Therapy Business (2017-2022)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs